VOYA Investment Management’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,977
| Closed | -$550K | – | 2718 |
|
|
2020
Q3 | $550K | Hold |
15,977
| – | – | ﹤0.01% | 1620 |
|
|
2020
Q2 | $267K | Sell |
15,977
-6,828
| -30% | -$116K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $329K | Buy |
22,805
+863
| +4% | +$22.1K | ﹤0.01% | 1866 |
|
|
2019
Q4 | $734K | Buy |
21,942
+3,225
| +17% | +$90.2K | ﹤0.01% | 1644 |
|
|
2019
Q3 | $392K | Hold |
18,717
| – | – | ﹤0.01% | 1907 |
|
|
2019
Q2 | $390K | Buy |
18,717
+732
| +4% | +$15.1K | ﹤0.01% | 1940 |
|
|
2019
Q1 | $402K | Hold |
17,985
| – | – | ﹤0.01% | 1898 |
|
|
2018
Q4 | $430K | Buy |
17,985
+1,053
| +6% | +$27.2K | ﹤0.01% | 1821 |
|
|
2018
Q3 | $462K | Hold |
16,932
| – | – | ﹤0.01% | 1883 |
|
|
2018
Q2 | $455K | Buy |
16,932
+1,151
| +7% | +$35.2K | ﹤0.01% | 1888 |
|
|
2018
Q1 | $502K | Hold |
15,781
| – | – | ﹤0.01% | 1799 |
|
|
2017
Q4 | $597K | Hold |
15,781
| – | – | ﹤0.01% | 1729 |
|
|
2017
Q3 | $391K | Hold |
15,781
| – | – | ﹤0.01% | 2022 |
|
|
2017
Q2 | $324K | Buy |
15,781
+3,757
| +31% | +$71.7K | ﹤0.01% | 2109 |
|
|
2017
Q1 | $261K | Hold |
12,024
| – | – | ﹤0.01% | 2133 |
|
|
2016
Q4 | $246K | Hold |
12,024
| – | – | ﹤0.01% | 2181 |
|
|
2016
Q3 | $180 | Hold |
12,024
| – | – | ﹤0.01% | 2336 |
|
|
2016
Q2 | $130K | Buy |
+12,024
| New | +$163K | ﹤0.01% | 2417 |
|
VOYA Investment Management's AIMT Position: Q4 2020 in Review
VOYA Investment Management sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 15,977 shares — an estimated $550K sold.
VOYA Investment Management first reported a position in AIMT in Q2 2016 and held it in 18 quarters. The position peaked at $734K in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- VOYA Investment Management reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- VOYA Investment Management sold 15,977 Aimmune Therapeutics shares in Q4 2020, an estimated $550K.
- VOYA Investment Management first reported a position in Aimmune Therapeutics in Q2 2016 and held it in 18 quarters.
- VOYA Investment Management's Aimmune Therapeutics position peaked at $734K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on VOYA Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.